EMEA-001169-PIP01-11-M04

Key facts

Invented name
Praluent
Active substance
Alirocumab
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0047/2018
PIP number
EMEA-001169-PIP01-11-M04
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of elevated cholesterol
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Sanofi-aventis Recherche & Développement

Tel. +33 1697 45662
E-mail: contact-us@sanofi.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating